Friday, March 27, 2009

Regulators Cast Wary Eye On Deals to Delay Generics

A $2.1 million settlement is the latest reminder over the trouble that can follow when branded drug makers cut deals with generics manufacturers.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)